Bioscience Americas ...Solutions for a Healthier World.
Regenerative medicine using stem cell therapy is proving to be the future of medical treatment for many degenerative diseases and injuries. Stem cells have the remarkable potential to develop into any cell type in the body. They serve as the body’s primary internal repair system, dividing essentially without limit to replenish other cells. If there is an injury, chronic disease or inflammation a stem cell has the potential to differentiate into whatever cell type is needed to fix the problem such as a muscle cell, a bone cell, or a nerve cell etc. When healthy stem cells are injected into the injured area, they work primarily by turning on and augmenting the body’s own repair mechanism. This treatment has a proven track record in Europe and other foreign markets in thousands of patients.
Bioscience Americas LLC was formed to provide working capital for, and to collaborate with, the Global Institute of Stem Cell Therapy and Research and its development affiliate GIOSTAR Colombia International, hereinafter collectively referred to as GIOSTAR Colombia, to bring adult stem cell based regeneration and rejuvenation treatment to patients throughout the world suffering from many debilitating diseases and illnesses.
GIOSTAR Colombia is one of the world’s leading stem cell research institutions. It has been involved in stem cell research work for more than fifteen years. GIOSTAR Colombia scientists are associated with many leading medical research universities including the University of California San Diego, University of Los Angeles and Harvard University.
Every year more than $50 million is invested in continued research providing solutions for life threatening diseases and illnesses. To date, GIOSTAR Colombia has been the beneficiary of more than $400 million in research grants, endowment contributions and legislative appropriations.